These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Price type key:
Federal Supply Schedule (FSS): generally available to all Federal Govt agencies /
'BIG4' prices: VA, DoD, Public Health & Coast Guard only /
National Contracts (NC): Available to specific agencies
Market Analysis and Price Projections for NDC 62135-0616
Last updated: March 13, 2026
What is NDC 62135-0616?
NDC 62135-0616 refers to a specific drug product listed in the National Drug Code (NDC) directory. This code corresponds to a branded or generic medication approved by the FDA. Based on publicly available data, NDC 62135-0616 is identified as [Drug Name and Description].
Note: The specific drug name and details are not provided in the initial query; analysis is based on typical NDC code insights.
Market Overview
Current Market Size
The drug serves a niche market within [Therapeutic Area].
Estimated annual sales revenue in the U.S. amounts to approximately $[X] million.
Market growth rate is approximately [Y]% annually, driven by increasing prevalence of [target condition].
Key Competitors
Product Name
Market Share
Price Range
Approval Year
Manufacturer
Competitor A
[X]%
$[Y]–$[Z]
[Year]
[Company Name]
Competitor B
[X]%
$[Y]–$[Z]
[Year]
[Company Name]
NDC 62135-0616
N/A (new entry)
To be determined
[Year]
[Manufacturer]
Regulatory Status
Approved by the FDA since [Year].
Currently marketed in [states/regions].
Pending or expected approvals for [adjunct therapies, extensions].
Price Analysis
Current Pricing Dynamics
The average wholesale price (AWP) for the generic equivalent is approximately $[X] per unit.
The branded version, if available, commands prices from $[Y] to $[Z] per unit.
Reimbursement rates vary depending on payer policies; Medicare and Medicaid reimbursements typically align with $[amount] per dosage.
Pricing Trends
Prices have increased by [X]% over the past 3 years, aligned with inflation and manufacturing cost rises.
Entry of the product has led to price stabilization for similar therapies, but premium positioning could command a higher price point.
Factors Influencing Future Pricing
Patent status and exclusivity periods.
Competition from generics or biosimilars.
Insurance coverage policies and formulary inclusion.
Manufacturing costs and supply chain stability.
Price Projections
Year
Projected Average Price per Unit
Assumptions
2023
$[X]
Current market conditions, patent protection intact
Given early market entry, the initial price premium may decline as competitors introduce generics.
In the absence of biosimilar threats, prices could stabilize or grow modestly at [X]%–[Y]% annually.
Market Entry Considerations
Pricing strategies must balance profitability and payer acceptance.
Early negotiations with payers could influence reimbursement levels.
A differentiated formulation or delivery method could command higher prices.
Outlook Summary
Market size for NDC 62135-0616 is projected to grow [Y]% annually over the next 5 years.
Price trajectory depends on patent protection, competition, and payer dynamics.
Initial pricing likely aligned with current market averages for similar therapies, with potential for premium positioning upon exclusive rights.
Key Takeaways
NDC 62135-0616 addresses a niche within [Therapeutic Area] with steady market growth.
Current prices reflect a competitive landscape with standard reimbursement rates.
Future pricing hinges on patent status, market competition, and regulatory decisions.
Early pricing should consider payer requirements and market expectations for optimal uptake.
Long-term value may be enhanced through differentiation and securing exclusive rights.
FAQs
What is the primary therapeutic use of NDC 62135-0616?
The medication is used to treat [specific condition], addressing an unmet need in [patient population].
What is the patent status of this drug?
The patent expires in [year], after which generic competition is expected to impact pricing.
How does the current price compare with similar drugs?
It is approximately [X]% higher or lower than comparable therapies, driven by formulation and brand positioning.
What factors could impact future prices?
Patent expiration, biosimilar entry, payer negotiations, regulatory changes, and manufacturing costs.
Is there potential for market expansion?
Yes, beyond the U.S., markets with high prevalence of [conditions] and favorable regulatory pathways could expand adoption.
References:
[1] FDA. (2023). Approved drug products with therapeutic equivalence evaluations. U.S. Food and Drug Administration.
[2] IQVIA. (2022). National Prescription Audit.
[3] EvaluatePharma. (2022). World Market Outlook and Trends.
[4] Centers for Medicare & Medicaid Services. (2022). Reimbursement policies for prescription drugs.
[5] MedPage Today. (2022). Market dynamics and competitive landscape for specialty medications.
Note: Precise data about NDC 62135-0616 is limited; this analysis is built on standard industry parameters and assumptions.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models.
By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
